A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

NCT00566397 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: PF-04494700
DRUG: PF-04494700
DRUG: Placebo

Sponsor

Pfizer

Collaborators

[object Object]